Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 390561 - 390580 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Saudi Arabia | (L04AE01) fingolimod (adm: O) | Sphingolin | 60 Blister, 0.5 mg, Oral use, Capsule, hard, 0.5mg , Blister, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
n/a | SaudiAmarox / HeteroLabsLimitedUnit–V |
| Saudi Arabia | (L04AE04) ponesimod (adm: O) | Ponvory (Initiation pack) | 14 Blister, 2,3,4,5,6,7,8,9,10 mg, Oral use, Film-coated tablet, 2,3,4,5,6,7,8,9,10mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | Janssen-CilagInternationalNV / JANSSENPHARMACEUTICAN.V. |
| Saudi Arabia | (L04AE04) ponesimod (adm: O) | Ponvory (maintenance pack) | 28 Blister, 20 mg, Oral use, Film-coated tablet, 20mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | Janssen-CilagInternationalNV / JANSSENPHARMACEUTICAN.V. |
| Saudi Arabia | (L04AE02) ozanimod (adm: O) | Zeposia | 28 Blister, 0.92 mg, Oral use, Capsule, hard, 0.92mg , Blister, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting; Colitis, Ulcerative | BristolMyersSquibbPharmaEEIG / CELGENEINTERNATIONAL |
| Saudi Arabia | (L04AE02) ozanimod (adm: O) | Zeposia (initiation pack) 4 caps 0.23 mg and 3 caps 0.46 mg | 7 Blister, 0.23+0.46 mg, Oral use, Capsule, hard, 0.23+0.46mg , Blister, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting; Colitis, Ulcerative | BristolMyersSquibbPharmaEEIG / CELGENEINTERNATIONAL |
| Saudi Arabia | (L04AE01) fingolimod (adm: O) | Figoya | 28 Blister, 0.5 mg, Oral use, Capsule, hard, 0.5mg , Blister, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
n/a | ALRAZIPHARMAINDUSTRIES / Dr.Reddy’sLaboratoriesLtd.FormulationUnitVII |
| Saudi Arabia | (L04AB01) etanercept (adm: P) | Nepexto | 4 Pre-filled syringe, 25 mg, Subcutaneous use, Solution for injection in pre-filled syringe, 25mg , Pre-filled syringe, Solution for injection in pre-filled syringe | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Arthritis, Psoriatic; Spondylarthropathies; Spondylitis, Ankylosing; Psoriasis | BostonOncologyArabia / LupinLimitedBiotechdivision |
| Saudi Arabia | (L04AB02) infliximab (adm: P) | Renflexis | 1 Vial, 100 mg, Intravenous use, Powder for concentrate for solution for infusion, 100mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | SamsungBioepisCoLtd / SamsungBiologics |
| Saudi Arabia | (L04AB04) adalimumab (adm: P) | Amgevita 20 mg per 0.4 ml | 1 Pre-filled syringe, 20 mg/ml, Subcutaneous use, Solution for injection, 20mg/ml , Pre-filled syringe, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic; Colitis, Ulcerative; Arthritis, Juvenile Rheumatoid; Spondylitis, Ankylosing; Psoriasis; Crohn Disease; Arthritis, Rheumatoid | AmgenEuropeBV / AMGENMANUFACTURINGLIMITED |
| Saudi Arabia | (L04AC07) tocilizumab (adm: P) | Tyenne 162 mg per 0.9 ml | 4 Pre-filled syringe, 180 mg/ml, Subcutaneous use, Solution for injection, 180mg/ml , Pre-filled syringe, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Cytokine Release Syndrome; Arthritis, Juvenile Rheumatoid; COVID-19 virus infection; Giant Cell Arteritis | BostonOncologyArabia / FreseniusKabiAustriaGmbH |
| Saudi Arabia | (L04AC07) tocilizumab (adm: P) | Tyenne 200 mg per 10 ml | 1 Vial, 10ml, 20 mg/ml, Intravenous use, Solution for infusion, 20mg/ml , Vial, Solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Cytokine Release Syndrome; Arthritis, Juvenile Rheumatoid; COVID-19 virus infection; Giant Cell Arteritis | BostonOncologyArabia / FreseniusKabiAustriaGmbH |
| Saudi Arabia | (L04AC07) tocilizumab (adm: P) | Tyenne 400 mg per 20 ml | 1 Vial, 20ml, 20 mg/ml, Intravenous use, Solution for infusion, 20mg/ml , Vial, Solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Cytokine Release Syndrome; Arthritis, Juvenile Rheumatoid; COVID-19 virus infection; Giant Cell Arteritis | BostonOncologyArabia / FreseniusKabiAustriaGmbH |
| Saudi Arabia | (L04AC07) tocilizumab (adm: P) | Tyenne 80 me per 4 ml | 1 Vial, 4ml, 20 mg/ml, Intravenous use, Solution for infusion, 20mg/ml , Vial, Solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Cytokine Release Syndrome; Arthritis, Juvenile Rheumatoid; COVID-19 virus infection; Giant Cell Arteritis | BostonOncologyArabia / FreseniusKabiAustriaGmbH |
| Saudi Arabia | (L04AH02) everolimus (adm: O) | CERTICAN 0.25MG TABLETS | 60 Blister, 0.25 mg, Oral use, Tablet, 0.25mg , Blister, Tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | NOVARTIS / NOVARTISPharmaSteinAG |
| Saudi Arabia | (L04AH02) everolimus (adm: O) | CERTICAN 0.75MG TABLETS | 60 Blister, 0.75 mg, Oral use, Tablet, 0.75mg , Blister, Tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | NOVARTIS / NOVARTISPharmaSteinAG |
| Saudi Arabia | (L04AG04) belimumab (adm: P) | BENLYSTA 120MG POWDER FOR SOLUTION FOR INFUSION | 1 Vial, 120 mg, Intravenous use, Powder for concentrate for solution for infusion, 120mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSaudiArabiaLtd / HOSPIRA |
| Saudi Arabia | (L04AG04) belimumab (adm: P) | BENLYSTA 400MG POWDER FOR SOLUTION FOR INFUSION | 1 Vial, 400 mg, Intravenous use, Powder for concentrate for solution for infusion, 400mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSaudiArabiaLtd / HOSPIRA |
| Saudi Arabia | (L04AF01) tofacitinib (adm: O) | Trijan | 56 Blister, 10 mg, Oral use, Film-coated tablet, 10mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | JazeeraPharmaceuticalIndustries(JPI) / TheArabPharmaceuticalManufacturingPSC(Sahab)CoLtd |
| Saudi Arabia | (L04AF01) tofacitinib (adm: O) | Trijan | 60 Blister, 5 mg, Oral use, Film-coated tablet, 5mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | JazeeraPharmaceuticalIndustries(JPI) / TheArabPharmaceuticalManufacturingPSC(Sahab)CoLtd |
| Saudi Arabia | (L04AF01) tofacitinib (adm: O) | XELJANZ 5 mg film-coated tablet | 60 Tablet Container, 5 mg, Oral use, Film-coated tablet, 5mg , Tablet Container, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | PFIZER / PFIZER |
Pages
